Reaction
Vital Capacity Decreased reporting signals
As of the last recalculation, Vital Capacity Decreased appears in 445 FAERS reports alongside 29 co-occurring drug terms. The strongest observed disproportionality signal is MEPOLIZUMAB (PRR 294.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Mepolizumab | 184 | 294.6 | 295.7 |
| Rabeprazole | 90 | 237.9 | 238.8 |
| Rosuvastatin Calcium | 95 | 200.3 | 201.0 |
| Theophylline | 43 | 193.6 | 194.3 |
| Theophylline Anhydrous | 45 | 188.8 | 189.4 |
| Rabeprazole Sodium | 75 | 154.5 | 154.9 |
| Montelukast Sodium | 200 | 138.7 | 138.9 |
| Ciclesonide | 37 | 138.5 | 138.9 |
| Omalizumab | 157 | 132.6 | 132.8 |
| Meloxicam | 101 | 104.9 | 105.1 |
| Escitalopram Oxalate | 100 | 82.5 | 82.6 |
| Diazepam Oral Solution (Concentrate) | 104 | 71.0 | 71.1 |
| Diazepam Oral | 104 | 71.0 | 71.1 |
| Fluticasone Furoate And Vilanterol Trifenatate | 44 | 63.4 | 63.5 |
| Budesonide And Formoterol Fumarate Dihydrate | 99 | 61.1 | 61.1 |
| Bisoprolol Fumarate | 125 | 59.5 | 59.5 |
| Mercaptopurine | 19 | 53.5 | 53.5 |
| Diazepam | 106 | 53.2 | 53.2 |
| Ipratropium Bromide | 34 | 48.2 | 48.2 |
| Tiotropium Bromide | 107 | 47.8 | 47.8 |
| Tiotropium Bromide Inhalation Spray | 11 | 47.0 | 47.1 |
| Montelukast | 69 | 45.3 | 45.4 |
| Budesonide | 50 | 44.6 | 44.6 |
| Escitalopram | 101 | 43.3 | 43.3 |
| Alendronate Sodium Tablet | 16 | 41.9 | 41.9 |
| Cetirizine Hydrochloride Allergy | 24 | 39.1 | 39.2 |
| Cetirizine Hydrochloride Tablets | 24 | 39.1 | 39.1 |
| Mometasone Furoate | 32 | 38.6 | 38.7 |
| Imatinib | 10 | 27.1 | 27.1 |